Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Ovulation Induction in Clinical Trial 107010 for the Development of Org 36286 (Corifollitropin Alfa)
Brief Summary: The objective of follow-up study P05713 is to evaluate whether corifollitropin alfa (Org 36286) treatment for the induction of monofollicular growth in women who underwent ovulation induction (OI) in base study P05693 (NCT00697255) is safe for pregnant participants and their offspring.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: corifollitropin alfa | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: corifollitropin alfa | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: corifollitropin alfa | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Follitropin beta injection | Intervention Type: DRUG; Name: corifollitropin alfa; Assigned to Arm(s): 1, 2, 3 | Intervention Type: DRUG; Name: Follitropin beta injection; Assigned to Arm(s): 4
B: Arm Label: Mothers Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Drug: Corifollitropin Alfa 150 μg, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: Mothers recFSH 200 IU; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin Alfa 150 μg; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU
C: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286; Assigned to Arm(s): Experimental Group 1 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 2
D: Arm Label: corifollitropin alfa + recFSH Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: recombinant Follicle Stimulating Hormone (recFSH), Biological: hCG Bolus injection | Arm Label: corifollitropin alfa + hCG Mothers; Type: N/A; Interventions: Drug: corifollitropin alfa, Biological: human Chorion Gonadotropin (hCG), Biological: hCG Bolus injection | Intervention Type: DRUG; Name: corifollitropin alfa; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: recombinant Follicle Stimulating Hormone (recFSH); Assigned to Arm(s): corifollitropin alfa + recFSH Mothers | Intervention Type: BIOLOGICAL; Name: human Chorion Gonadotropin (hCG); Assigned to Arm(s): corifollitropin alfa + hCG Mothers | Intervention Type: BIOLOGICAL; Name: hCG Bolus injection; Assigned to Arm(s): corifollitropin alfa + hCG Mothers, corifollitropin alfa + recFSH Mothers

Answer: D